Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Longview Acquisition Stock Popped Today

By Evan Niu, CFA - Nov 24, 2020 at 2:13PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A prominent fund manager has initiated a position in the special purpose acquisition company.

What happened

Shares of Longview Acquisition ( LGVW ) have popped today, up by 16% as of 1:15 p.m. EST, after ARK Invest bought approximately 460,000 shares  for its Ark Genomic Revolution ETF ( ARKG -4.59% ). Longview Acquisition is a special purpose acquisition company (SPAC) that recently announced that it is merging with Butterfly Network, which makes a portable ultrasound device and accompanying app.

So what

Longview, which will soon change its ticker symbol to BFLY after the merger closes, now represents a modest 0.17% of the exchange-traded fund (ETF), but ARK CEO and CIO Cathie Wood has a history of continuing to add to new positions after initiating a small stake.

Butterfly's ultrasound device and app

Image source: Butterfly Network.

The ARK Genomic Revolution fund's objective  is to invest in companies that incorporate advanced scientific technology and genomics into their business. The fund was created in 2014 and has $2.3 billion in assets under management (AUM). Unlike most ETFs that are passively managed, the ARK Genomic Revolution is actively managed and therefore carries a higher expense ratio (0.75%) compared with passive funds.

Now what

Along with the merger, Longview is looking to raise an additional $175 million from investors as part of a private investment in public equity (PIPE) deal. Longview currently has $414 million in cash. Butterfly is attempting to disrupt an $8 billion addressable market with its ultrasound technology platform, which will provide low-cost medical imaging.

The merger is expected to close in the first quarter of 2021.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Longview Acquisition Corp. Stock Quote
Longview Acquisition Corp.
LGVW
ARK ETF Trust - ARK Genomic Revolution ETF Stock Quote
ARK ETF Trust - ARK Genomic Revolution ETF
ARKG
$60.46 (-4.59%) $-2.91

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
656%
 
S&P 500 Returns
144%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/01/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.